Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
Phase 1
20
about 4.7 years
18+
1 site in FL
What this study is about
Researchers are testing whether a new imaging agent, 18F-fluciclovine, can detect which patients are responding to radiation therapy. The trial will also look at how the treated brain metastases change over time using this imaging agent.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 18F fluciclovine
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
fluciclovine (18F)
Primary: Change in sensitivity for MRI, Change in the standardized uptake value (SUV) parameters
Secondary: Compare change of SUV metrics of 18F-fluciclovine PET, Compare change of SUV metrics of contrast-enhanced MRI